Cue Health, the once high-flying San Diego biotech supplying rapid COVID-19 test kits to the NBA and Google, is laying off all employees and shutting down on Friday. Cue’s closure comes a week after ...

Covid-19 test maker Cue Health went public on Friday at a valuation of nearly $2.3 billion. Shares opened above the $16 price set the night before and closed at $20—a 25% increase in the first day of ...

After racking up hundreds of millions in venture capital throughout the pandemic to support its COVID-19 test-making business, Cue Health will look to make its break into the public market with an IPO ...

Makers of COVID-19 testing tools are raking in billions while many consumers pay through the nose to find out if they are infected. Over-the-counter rapid tests have been pricey since they first ...

On Friday, the Food and Drug Administration issued an emergency authorization for the first at-home test that can detect flu and Covid-19 — but for the test’s maker, Lucira, the long-anticipated ...

Aug 13 (Reuters) - Grail Inc (GRAL.O), opens new tab said on Tuesday it has cut about 350 existing jobs as the diagnostics company focuses on the development of its flagship cancer-detection test ...

To add a new question, simply click on the green Plus icon on the left panel. You can also insert media to a particular question, including images, video, sound, VLC media player file, Windows media ...